Results 161 to 170 of about 34,531 (282)

Modalities of Vitamin D Administration to Preterm Infants: Impact on 25 OH Vitamin D Levels

open access: yes
Acta Paediatrica, Volume 115, Issue 4, Page 985-987, April 2026.
Sophie Laborie   +3 more
wiley   +1 more source

Distribution of Sentinel Nodes in Non‐Parotid Salivary Gland Tumors—A Feasibility Study

open access: yesCancer Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background Salivary gland carcinomas are rare and heterogeneous malignancies, more common in the parotid gland but also in submandibular and minor salivary glands. Surgery, often combined with radiotherapy, is the main treatment. Management of the clinically node‐negative (cN0) neck is debated, with some favoring extensive surgery and others ...
Marcus Jansson   +4 more
wiley   +1 more source

Assessment of Quality of Care Provided for Patients Receiving Post‐Myocardial Infarction Care at Selected Cardiac Clinics in Sulaymaniyah: Cross‐Sectional Study

open access: yesHealth Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background According to global projections, by the year 2050, ischemic heart disease will remain the leading cause of cardiovascular deaths with hypertension as a leading modifiable risk factor for mortality. Improving quality care for patients with acute myocardial infarction (MI) is associated with improved outcomes. Aims There is inadequate
Banaz Sadiq Elias   +2 more
wiley   +1 more source

Glyceryl trinitrate absorption: chewing versus sublingual administration

open access: yesInternational Journal of Clinical Practice, 1986
J K, Mettle   +3 more
openaire   +2 more sources

Cohort Study to Determine the Impact of CYP3A5 Genotype on Tacrolimus Dosing Requirements and Trough Concentrations in Heart Transplant Recipients

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 46, Issue 3, March 2026.
ABSTRACT Background Tacrolimus is primarily metabolized by Cytochrome P450 (CYP)3A4/5. The Clinical Pharmacogenetics Implementation Consortium recommends increasing the initial dose 1.5‐ to 2‐fold in CYP3A5 expressers to enhance transplant outcomes. Our objective was to investigate the impact of CYP3A5 expresser status on tacrolimus dosing requirements
Yanting Wu   +6 more
wiley   +1 more source

Xylazine test strip utilization among pregnant and postpartum women with opioid use disorder: A pilot study

open access: yesPregnancy, Volume 2, Issue 2, March 2026.
Abstract Introduction The emergence of xylazine, a veterinary alpha‐2 and kappa opioid receptor agonist, as an adulterant in illicitly manufactured fentanyl has created new challenges and risks for pregnant people who use unregulated opioids. Xylazine test strips (XTSs) have been proposed as a harm reduction strategy, but their use has not been studied
Ilana Hull   +7 more
wiley   +1 more source

Unveiling the Invisible: A Case of Canine Diffuse Microscopic Pancreatic Adenocarcinoma With Normal Imaging and Gross Appearance of the Pancreas Complicated by Sterile Peritonitis and Disseminated Intravascular Coagulation

open access: yesVeterinary Medicine and Science, Volume 12, Issue 2, March 2026.
This case report describes an atypical presentation of diffuse microscopic pancreatic adenocarcinoma in an 11‐year‐old male neutered Shetland Sheepdog, which was not detectable on advanced diagnostic imaging or during exploratory laparotomy. Despite the absence of visible pancreatic abnormalities, histopathology confirmed malignant infiltration ...
Hiu Man Chan   +7 more
wiley   +1 more source

Quality of Medication Abortion Services From Pharmacies and Drugstores in Ethiopia: A Two‐Stage Study

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 4, Page 796-804, March 2026.
ABSTRACT Objective To assess the quality of medication abortion (MA) services provided in pharmacies and drugstores (‘pharmaceutical outlets’) in Ethiopia. Design A two‐stage cross‐sectional study. Setting Pharmaceutical outlets in Addis Ababa, Ethiopia.
Tesfaye Tufa   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy